TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070 | -2.7% | 70 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,100 | -4.7% | 70 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,154 | +5.7% | 70 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,092 | +9.2% | 70 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,000 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |